Answers are grounded in this paper and cite their sources.
To compare apical root resorption (ARR) following clear-aligner versus conventional fixed-appliance treatment in young adults with Class I malocclusion and severe crowding requiring extraction of four first premolars. A single-center, two-arm, parallel-group randomized controlled trial with 1:1 allocation. Department of Orthodontics, Faculty of Dentistry, Damascus University, Syria. Forty adults aged 18–25 years were randomly allocated to in-house clear aligners (CA; n = 20) or conventional fixed appliances (FA; n = 20). ARR was calculated as the positive reduction in tooth length from pretreatment to post-treatment using cone-beam computed tomography. An external researcher generated a simple random allocation sequence using Minitab 18.1. Consecutively numbered, opaque, sealed envelopes were used. The outcome assessor and data analyst were blinded to allocation. Participants and the treating clinician could not be blinded. All 40 participants completed the trial and were analyzed in their allocated groups. Mean ARR ranged from 0.41 to 0.77 mm in the CA group and from 0.14 to 1.35 mm in the FA group. After Bonferroni correction ( P < 0.005), greater ARR was estimated in the FA group for maxillary canines (mean difference, CA minus FA: −0.80 mm; 95% CI − 1.12 to − 0.48), mandibular first molars (− 0.66 mm; −0.76 to − 0.56), maxillary central incisors (− 0.55 mm; −0.78 to − 0.32), maxillary lateral incisors (− 0.53 mm; −0.77 to − 0.29), and mandibular canines (− 0.39 mm; −0.52 to − 0.26). No harms or unintended adverse events were observed. Both treatment modalities resulted in mild apical root resorption. Statistically significant between-group differences were identified for five evaluated tooth types, with greater resorption in the fixed appliance group. However, the absolute differences were small and remained within clinically acceptable limits. Clear aligners demonstrated a biological safety profile comparable to conventional fixed appliances in this specific sample. ClinicalTrials.gov, NCT07236775.
No takes yet. Share an insight, caveat, or question.
Jaber et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: